Figure 1.
Effects of allocation to simvastatin plus ezetimibe on vascular access occlusive events among SHARP participants with preexisting access at randomization. CI, confidence interval; SHARP, Study of Heart and Renal Protection.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.